To evaluate whether 4T1 tumor-infiltrating T cells were functionally active, we analyzed the expression of immune checkpoint inhibitory receptors PD-1 and CTLA-4, T-box transcription factor EOMES, and cytokine production of intratumor CD8+ T cells by flow cytometry. This evidence concerns the gene CD8A and neoplasm.